Los Angeles Capital Management LLC Viatris Inc Transaction History

Los Angeles Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$8.72 - $11.56 $1.29 Million - $1.71 Million	-148,059 Reduced 34.47%	281,471 $3.13 Million
Q3 2022 Nov 02, 2022	SELL	$8.48 - $11.13 $708,877 - $930,401	-83,594 Reduced 16.29%	429,530 $3.66 Million
Q2 2022 Aug 05, 2022	BUY	$9.95 - $12.27 $3.92 Million - $4.83 Million	393,565 Added 329.18%	513,124 $5.37 Million
Q1 2022 May 06, 2022	BUY	$9.81 - $15.4 $1.01 Million - $1.59 Million	102,937 Added 619.28%	119,559 $1.3 Million
Q4 2021 Feb 03, 2022	SELL	$12.09 - $14.68 $2.92 Million - $3.55 Million	-241,718 Reduced 93.57%	16,622 $225,000
Q3 2021 Nov 08, 2021	SELL	$13.25 - $15.13 $2.09 Million - $2.38 Million	-157,444 Reduced 37.87%	258,340 $3.5 Million
Q2 2021 Aug 05, 2021	SELL	$12.97 - $16.15 $3.89 Million - $4.85 Million	-300,144 Reduced 41.92%	415,784 $5.94 Million
Q1 2021 May 05, 2021	BUY	$13.59 - $18.54 $7.76 Million - $10.6 Million	571,267 Added 394.9%	715,928 $10 Million
Q4 2020 Feb 04, 2021	BUY	$14.3 - $18.74 $2.07 Million - $2.71 Million	144,661 New	144,661 $2.71 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.